Award

Supply of Additive Solutions for the Suspension of Blood Products

  • NHS Blood and Transplant

F15: Voluntary ex ante transparency notice

Notice identifier: 2022/S 000-036161

Procurement identifier (OCID): ocds-h6vhtk-039338

Published 21 December 2022, 11:03am



Section one: Contracting authority/entity

one.1) Name and addresses

NHS Blood and Transplant

500 North Bristol Park

Bristol

BS34 7QH

Contact

Samantha Rix

Email

samantha.rix@nhsbt.nhs.uk

Telephone

+44 7385972251

Country

United Kingdom

Region code

UKK11 - Bristol, City of

National registration number

NHS Blood and Transplant

Internet address(es)

Main address

https://www.nhsbt.nhs.uk/

Buyer's address

https://www.nhsbt.nhs.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Supply of Additive Solutions for the Suspension of Blood Products

Reference number

C27251 (NHSBT1075)

two.1.2) Main CPV code

  • 33194220 - Blood-transfusion supplies

two.1.3) Type of contract

Supplies

two.1.4) Short description

NHSBT uses Platelet Additive Solution (PAS) for the suspension and storage of pooled platelets, and Saline Adenine Glucose Mannitol (SAGM) solution in the manufacture and storage of washed red cells.

The framework agreement was awarded to MacoParma after an OJEU open tender exercise on behalf of selected beneficiaries (blood services from the UK, Ireland, Australia and New Zealand).

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £5,464,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKK11 - Bristol, City of
Main site or place of performance

UK

two.2.4) Description of the procurement

This Framework Agreement was let for a period of 4-years starting on 01/12/2018, and expired on 30/11/2022. Due to circumstances outside of the Authority's control, including dealing with the impact of Covid-19 and a related procurement exercise being delayed, the Authority wishes to extend this Framework Agreement by 1-Year. This extension will allow the Authority adequate time to complete the related procurement exercise, and allow sufficient time to carry out the required validation exercise for the retendering of this requirement.

Therefore, this VEAT notice will cover the period 1 December 2022 to 30 November 2023.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

This Framework Agreement was let for a period of 4-years starting on 01/12/2018, and expired on 30/11/2022. Due to circumstances outside of the Authority's control, including dealing with the impact of Covid-19 and a related procurement exercise being delayed, the Authority wishes to extend this Framework Agreement by 1-Year. This extension will allow the authority adequate time to complete the related procurement exercise, and allow sufficient time to carry out the required validation exercise for the retendering of this requirement.

Therefore, this VEAT notice will cover the period 1 December 2022 to 30 November 2023.

four.1.3) Information about a framework agreement

The procurement involves the establishment of a framework agreement

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2018/S 188-424547


Section five. Award of contract/concession

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

1 December 2022

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

MacoPharma UK Limited

9th Floor- Regal House, 70 London Road, Twickenham, Middlesex,

Twickenham

TW13QS

Telephone

+44 7764253357

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

01986987

Internet address

www.macopharma.com

The contractor/concessionaire is an SME

No

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Initial estimated total value of the contract/lot/concession: £464,000

Total value of the contract/lot/concession: £464,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

The High Court

The Strand

London

WC2A 2LL

Country

United Kingdom

Internet address

https://www.judiciary.uk/courts-and-tribunals/high-court/